RARECELLS INC.
Company Snapshot
Founded: 2010
Entity Type: Private
Region: France
Headquarter: Paris, France
Key Geographics: France, U.S.
Corporate Address: 101 rue de Sevres 75 280 Paris Cedex 06 France Tel. + 33-0-1-4061-5602 www.rarecells.com
Company Overview
Rarecells, Inc. is developing and commercializing CTC isolation technology based on size filtration.
RareCell’s technology platform is called ISET (Isolation by Size of Epithelial/Throphoblastic Tumor cells). ISET uses filtration to separate cells based on their size, with the larger cells, including CTCs, being retained on the filter.
The company’s products include a CE-IVD labeled instrument for extracting tumor cells from blood; RareCells Block (filtration of blood samples); RareCells Buffer reagents (for dilution of blood samples); and a system, launched in July 2020, designed for high-resolution spatial analysis of tissue samples.
Company's Business Segments
- ISET technology : This segment of Rarecells Develops, Commercializes the ISET Technology to Isolate Circulating Cancer Cells for early Cancer Diagnosis, Medical Research.
Applications/End User Industries
- Cancer Diagnosis
- Medical Researchers
- Oncology
- ISET Technology
- Healthcare
- Academic Research
- Pharmaceuticals
BCC Research Beacon 